| pubmed-article:18945747 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0855112 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0393022 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0332157 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0332152 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C1422836 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C1824429 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0017243 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0085405 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:18945747 | lifeskim:mentions | umls-concept:C0171016 | lld:lifeskim |
| pubmed-article:18945747 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:18945747 | pubmed:dateCreated | 2008-12-3 | lld:pubmed |
| pubmed-article:18945747 | pubmed:abstractText | The role of re-treatment with rituximab in aggressive B-cell lymphomas still needs to be defined. This study evaluated the influence of prior exposure to rituximab on response rates and survival in patients with diffuse large B-cell lymphoma treated with rituximab plus etoposide, cytarabine, cisplatinum and methylprednisolone (R-ESHAP). | lld:pubmed |
| pubmed-article:18945747 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18945747 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18945747 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18945747 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:18945747 | pubmed:issn | 1592-8721 | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:VázquezLourde... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:MartínAlejand... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:GrandeCarlosC | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:CondeEulogioE | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:LeónAngelA | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:AndreuRafaelR | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:CanalesMiguel... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:SalarAntonioA | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:González-Barc... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:RuizConcepció... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:GonzálezJosé... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:SanchoJuan... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:DebenGuillerm... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:ArnanMontserr... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:García-Sanche... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:NistalSaraS | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:RequenaMaría-... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:DonatoEva MEM | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:CaballeroMarí... | lld:pubmed |
| pubmed-article:18945747 | pubmed:author | pubmed-author:Grupo... | lld:pubmed |
| pubmed-article:18945747 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:18945747 | pubmed:volume | 93 | lld:pubmed |
| pubmed-article:18945747 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18945747 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18945747 | pubmed:pagination | 1829-36 | lld:pubmed |
| pubmed-article:18945747 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:meshHeading | pubmed-meshheading:18945747... | lld:pubmed |
| pubmed-article:18945747 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18945747 | pubmed:articleTitle | R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study. | lld:pubmed |
| pubmed-article:18945747 | pubmed:affiliation | Department of Hematology, Complejo Hospitalario de Zamora, Avenida de Requejo 35, Zamora 49022, Spain. amartingar@aehh.org | lld:pubmed |
| pubmed-article:18945747 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18945747 | pubmed:publicationType | Multicenter Study | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18945747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18945747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18945747 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18945747 | lld:pubmed |
